TY - JOUR T1 - Age-stratified Infection Probabilities Combined with Quarantine-Modified SEIR Model in the Needs Assessments for COVID-19 JF - medRxiv DO - 10.1101/2020.04.08.20057851 SP - 2020.04.08.20057851 AU - Vena Pearl Bongolan AU - Jose Marie Antonio Minoza AU - Romulo de Castro AU - Jesus Emmanuel Sevilleja Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/11/2020.04.08.20057851.abstract N2 - We use the age-stratified COVID-19 infection and death distributions from China (more than 44,672 infectious as of February 11, 2020) as an estimate for a study area’s infection and morbidity probabilities at each age group. We then apply these probabilities into the actual age-stratified population to predict infectious individuals and deaths at peak. Testing with different countries shows the predicted infectious skewing with the country’s median age and age stratification, as expected. We added a Q parameter to the classic SEIR compartmental model to include the effect of quarantine (Q-SEIR). The projections from the age-stratified probabilities give much lower predicted incidences of infection than the Q-SEIR model. As expected, quarantine tends to delay the peaks for both Exposed and Infectious, and to ‘flatten’ the curve or lower the predicted values for each compartment. These two estimates were used as a range to inform planning and response to the COVID-19 threat.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. de Castro is currently supported by the Republic of the Philippines' Department of Science and Technology, Philippine Council for Health Research and Development - Balik Scientist Program.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and spreadsheets available. ER -